Alexander P. Underwood
Copenhagen, 2200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
SARS-CoV-2 Neutralization Breadth Is Shaped by Variant Exposure and Immune History.
Journal: Journal of medical virology
Published: November 20, 2025
Cure of chronic hepatitis C virus infection after DAA treatment only partially restores the functional capacity of exhausted T cell subsets: a systematic review.
Journal: Frontiers in immunology
Published: December 17, 2024
T cell receptor usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells.
Journal: Frontiers in immunology
Published: October 12, 2024
Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions.
Journal: Emerging microbes & infections
Published: October 11, 2024
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
Journal: Scientific reports
Published: April 16, 2024
Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.
Journal: Frontiers in immunology
Published: December 10, 2023
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
Journal: Communications biology
Published: October 31, 2023
B-cell characteristics define HCV reinfection outcome.
Journal: Journal of hepatology
Published: August 22, 2023
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination.
Journal: EBioMedicine
Published: November 12, 2022
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Journal: The Lancet. Microbe
Published: September 05, 2022
Last Updated: 09/26/2026